The impact of lecanemab and donanemab on future Alzheimer's disease clinical development.
Saved in:
| Title: | The impact of lecanemab and donanemab on future Alzheimer's disease clinical development. |
|---|---|
| Authors: | Dickson, Samuel P., Mallinckrodt, Craig, Burstein, Aaron H, Nisenbaum, Laura, Fillit, Howard M, Hendrix, Suzanne B. |
| Source: | Alzheimer's & dementia: the journal of the Alzheimer's Association Dec2024 Supplement; Vol. 20 (S6). |
| Journal Info: | Publisher: Wiley-Blackwell ISSN: 1552-5260 |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
